Treatment of xanthoma with azetidinone derivatives as sterol absorption inhibitors
Details for Australian Patent Application No. 2002336609 (hide)
International Classifications
Event Publications
20 February 2003 Complete Application Filed
Priority application(s): 60/323,942 21.09.01 US
26 June 2003 Application Open to Public Inspection
Published as AU-B-2002336609
24 August 2006 Application Accepted
Published as AU-B-2002336609
21 December 2006 Standard Patent Sealed
11 October 2012 Application for Amendment
The nature of the amendment is: Amend the Patentee to read Merck Sharp & Dohme Corp. . Address for service in Australia - Griffith Hack Level 29, Northpoint 100 Miller Street North Sydney NSW 2060
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser